Feasibility of assessing utilities with a single-item standard gamble questionnaire in patients with melanoma

by Christine Blome, Katharina C. Kähler, Tobias Wagner, Axel Hauschild, Matthias Augustin
Published 2021-08-01

Willingness to pay for a cure of low-risk melanoma patients in Germany.

by Matthias Augustin, Christine Blome, Andrea Forschner, Ralf Gutzmer, Axel Hauschild, Lucie Heinzerling, Elisabeth Livingstone, Carmen Loquai, Dirk Schadendorf, Jochen Utikal, Tobias Wagner, Sophia Wilden, Katharina C Kähler
Published 2018-01-01

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

by Joanna Mangana, Phil F Cheng, Katja Schindler, Benjamin Weide, Ulrike Held, Anna L Frauchiger, Emanuella Romano, Katharina C Kähler, Sima Rozati, Markus Rechsteiner, Holger Moch, Olivier Michielin, Claus Garbe, Axel Hauschild, Christoph Hoeller, Reinhard Dummer, Simone M Goldinger
Published 2015-01-01

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

by Markus V. Heppt, Teresa Amaral, Katharina C. Kähler, Lucie Heinzerling, Jessica C. Hassel, Markus Meissner, Nicole Kreuzberg, Carmen Loquai, Lydia Reinhardt, Jochen Utikal, Evelyn Dabrowski, Anja Gesierich, Claudia Pföhler, Patrick Terheyden, Kai-Martin Thoms, Lisa Zimmer, Thomas K. Eigentler, Michael C. Kirchberger, Henner M. Stege, Friedegund Meier, Max Schlaak, Carola Berking
Published 2019-11-01

Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial

by Theresa Steeb, Anja Wessely, Dagmar von Bubnoff, Thomas Dirschka, Konstantin Drexler, Conrad Falkenberg, Jessica C. Hassel, Kinan Hayani, Svea Hüning, Katharina C. Kähler, Sigrid Karrer, Christian Krammer, Ulrike Leiter, Diana Lill, Enklajd Marsela, Andreas Meiwes, Dorothée Nashan, Suzan Nasifoglu, Lutz Schmitz, Judith Sirokay, Alexander Thiem, Jochen Utikal, Alexander Zink, Carola Berking, Markus V. Heppt
Published 2020-05-01

Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study

by Katharina C. Kähler, Ralf Gutzmer, Friedegrund Meier, Friedegrund Meier, Lisa Zimmer, Markus Heppt, Anja Gesierich, Kai-Martin Thoms, Jochen Utikal, Jochen Utikal, Jessica C. Hassel, Carmen Loquai, Claudia Pföhler, Lucie Heinzerling, Lucie Heinzerling, Martin Kaatz, Daniela Göppner, Annette Pflugfelder, Ann-Sophie Bohne, Imke Satzger, Lydia Reinhardt, Lydia Reinhardt, Jan-Malte Placke, Dirk Schadendorf, Selma Ugurel
Published 2021-05-01

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis

by Elias A. T. Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Anja Gesierich, Ralf Gutzmer, Jessica C. Hassel, Sebastian Haferkamp, Bettina Hohberger, Katharina C. Kähler, Harald Knorr, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr, Claudia Pföhler, Farnaz Rahimi, Dirk Schadendorf, Beatrice Schell, Max Schlaak, Patrick Terheyden, Kai-Martin Thoms, Beatrice Schuler-Thurner, Selma Ugurel, Jens Ulrich, Jochen Utikal, Michael Weichenthal, Fabian Ziller, Carola Berking, Markus V. Heppt, on behalf of the German Dermatologic Cooperative Oncology Group (DeCOG, Committee Ocular Melanoma)
Published 2021-07-01